VICTORIA REESMAN: Open Payments
NPI 1235104076 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,430 in 21 payments from 12 companies in 2025. Trend: 2023 $188 · 2024 $169 · 2025 $1,430
Food & beverage: $1,331Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $285 |
| Pharmacosmos Therapeutics Inc. | 3 | $265 |
| BeOne Medicines USA, Inc. | 1 | $150 |
| CorMedix Inc. | 2 | $135 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Grifols USA, LLC | 1 | $125 |
| Syndax Pharmaceuticals, Inc. | 1 | $107 |
| SEAGEN INC. | 1 | $99 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Becton, Dickinson and Company | 1 | $36 |
Products named: BRUKINSA, MONOFERRIC, RYBREVANT, COSELA, Gamunex-C, DEFENCATH, REVUFORJ, TALVEY.
Industry payments across NY — which companies pay providers there.
